INIFY LABORATORIES ABINIFY LABORATORIES ABINIFY LABORATORIES AB

INIFY LABORATORIES AB

No trades
See on Supercharts
Market capitalization
‪17.84 M‬EUR
−0.098EUR
‪−4.72 M‬EUR
‪105.66 K‬EUR
‪6.66 M‬
Beta (1Y)
1.32
Employees (FY)
22
Change (1Y)
+9 +69.23%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About INIFY LABORATORIES AB


CEO
Fredrik Palm
Website
Headquarters
Solna
Founded
2021
ISIN
SE0017486103
FIGI
BBG018KM9FX1
INIFY Laboratories AB engages in the provision of cancer diagnostics through laboratory services within pathology. It offers services to urologists and hospitals with short and repeatable response time in terms of a structured diagnosis report sent directly into electronic health record system. The company was founded on November 10, 2021 and is headquartered in Solna, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange INIFY LABORATORIES AB stocks are traded under the ticker WY60.
WY60 reached its all-time high on Jan 2, 2024 with the price of 1.034 EUR, and its all-time low was 0.250 EUR and was reached on Jan 20, 2025. View more price dynamics on WY60 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track INIFY LABORATORIES AB financials in yearly and quarterly reports right on TradingView.
WY60 net income for the last quarter is ‪−1.04 M‬ EUR, while the quarter before that showed ‪−1.19 M‬ EUR of net income which accounts for 13.05% change. Track more INIFY LABORATORIES AB financial stats to get the full picture.
No, WY60 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 18, 2025, the company has 22.00 employees. See our rating of the largest employees — is INIFY LABORATORIES AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INIFY LABORATORIES AB EBITDA is ‪−4.25 M‬ EUR, and current EBITDA margin is ‪−4.31 K‬%. See more stats in INIFY LABORATORIES AB financial statements.
Like other stocks, WY60 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INIFY LABORATORIES AB stock right from TradingView charts — choose your broker and connect to your account.